World of DTC Marketing
AUGUST 16, 2020
Here is a copy of a talk I recently gave via Zoom to my European colleagues. Those of you who know me know that I am a frequent contributor to Hedley Rees books as well as the author of a blog that gets close to 100,000 reads a month. I have been and continue to be critical of the pharma industry but it’s not out of spite or hate. I am critical because I love this industry.
BioSpace
AUGUST 16, 2020
UNITY Biotechnology reported that the 12-week results from its Phase II study of UBX0101 in moderate-to-severe painful osteoarthritis (OA) of the knee failed to show improvement over placebo.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
pharmaphorum
AUGUST 16, 2020
Swittons , a P360 company, has announced a new line of Internet of Things (IoT) enabled smart devices built specifically for pharmaceutical labs. The fully customizable devices align with strategic Lab of the Future (LoTF) initiatives and help automate various laboratory workflows between people and existing digital lab equipment, systems and solutions.
BioSpace
AUGUST 16, 2020
The U.S. Food and Drug Administration approved Genentech’s Enspryng (satralizumab-mwge) as a subcutaneous treatment for adults with anti-aquaporin-4 (AQP4) antibody positive neuromyelitis optica spectrum disorder.
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
pharmaphorum
AUGUST 16, 2020
The European Commission has placed its first advance order for a coronavirus vaccine, snapping up 300 million doses of AstraZeneca’s ChAdOx1 candidate developed by the University of Oxford, with an option on another 100 million. ChAdOx1 – which is in large-scale phase 2/3 trials – was licensed by AZ in April and renamed AZD1222, and should be ready for first deliveries before the end of the year.
BioSpace
AUGUST 16, 2020
Under terms of the deal, Sanofi will acquire all of the outstanding shares of Principia for $100 per share in cash, which represents an aggregate equity value of approximately $3.68 billion.
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
BioSpace
AUGUST 16, 2020
Bristol Myers Squibb plunked down $475 million for the exclusive license to Dragonfly Therapeutics’ interleukin-12 (IL-12) investigational immunotherapy program.
Scienmag
AUGUST 16, 2020
Credit: RIPE team Crops grow dense canopies that consist of several layers of leaves–the upper layers with younger sun leaves and the lower layers with older shaded leaves that may have difficulty intercepting sunlight trickling down from the top layers. In a recent study published in Food and Energy Security, scientists from Realizing Increased Photosynthetic […].
BioSpace
AUGUST 16, 2020
“Today’s announcement puts another building block in place as the Nation moves toward a safe and effective COVID-19 vaccine,” stated Robert Redfield, director of the U.S. Centers for Disease Control and Prevention.
Scienmag
AUGUST 16, 2020
Blame, shame and disagreements between parents and grandparents over parenting choices like discipline, meals and TV time can strain relationships Credit: C.S. Mott Children’s Hospital National Poll on Children’s Health at Michigan Medicine. ANN ARBOR, Mich. — Cookies for breakfast, staying up late and maybe a little more TV than usual.
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
BioSpace
AUGUST 16, 2020
The 11-person team at Codagenix may be tiny, but it has big plans for the company’s new COVID-19 vaccine.
Scienmag
AUGUST 16, 2020
Analysis lead by Penn Medicine identified gender disparities in authorship of heart failure guideline citations and clinical trials PHILADELPHIA– While about a quarter of physicians and researchers working in advanced heart failure (HF) and transplant cardiology are women, representation of women leading HF research remains limited, according to new research led by Penn Medicine.
BioSpace
AUGUST 16, 2020
In the midst of an international pandemic, three high-profile public health officials are leaving government service.
JAMA Internal Medicine
AUGUST 16, 2020
This systematic review and meta-analysis evaluate the diagnostic accuracy of symptoms, physical signs, and laboratory tests in patients with suspected giant cell arteritis.
Advertisement
When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.
BioSpace
AUGUST 16, 2020
With a busy August on the U.S. Food and Drug Administration’s schedule, this week is no exception. Here’s a look at some of what’s on the agency’s calendar.
JAMA Internal Medicine
AUGUST 16, 2020
This cohort study uses data from a COVID-19 tracking project to assess the prevalence of COVID-19 infection by race/ethnicity in 12 US states.
BioSpace
AUGUST 16, 2020
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for August 17, 2020.
Scienmag
AUGUST 16, 2020
Review highlights that negative effects of nutrients from human activities in marine ecosystems are exacerbated by other factors such as climate change Excessive nutrients, such as nitrogen and phosphorus, have devastating effects on coastal marine ecosystems by causing algal blooms that deplete oxygen in the water, killing marine life. Such nutrients can enter the sea […].
Advertisement
This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.
The Pharma Data
AUGUST 16, 2020
Basel, 17 August 2020. First and only FDA-approved subcutaneous treatment option for anti-aquaporin-4 antibody positive NMOSD that can be self-administered by a person with NMOSD or a caregiver every four weeks. First and only approved therapy for NMOSD designed to target and inhibit interleukin-6 receptor activity, using novel recycling antibody technology.
pharmaphorum
AUGUST 16, 2020
The UK-based AI technology company Healx has begun a partnership with the Foundation for Angelman Syndrome Therapeutics (FAST), focusing on developing new therapies for the rare neurogenetic disorder. The latest project will focus on quickly identifying and progressing novel treatments for Angelman syndrome, which is caused by several genetic mutations.
The Pharma Data
AUGUST 16, 2020
Image copyright. Eva Larkai. Image caption. Eva Larkai, a fourth-year medical student, led the student group demanding change. A major British medical school is leading the drive to eliminate what it calls “inherent racism” in the way doctors are trained in the UK. The University of Bristol Medical School says urgent action is needed to examine why teaching predominantly focuses on how illnesses affect white people above all other sections of the population.
Scienmag
AUGUST 16, 2020
The goal: Bring lab therapeutics to patients’ bedsides in half the current time frame. Credit: SDSU When clinicians resort to phage therapy for patients who don’t respond to antibiotics, the patients are usually very ill and time is of the essence. But the average time for labs to produce therapeutic phages is more than a […].
Advertisement
As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.
BioSpace
AUGUST 16, 2020
It was a very busy week for clinical trial updates. Here’s a look.
Scienmag
AUGUST 16, 2020
New research published today in The Journal of Physiology shows that nitrate improves function in the diaphragm, the muscle involved in coughing and breathing, by improving power. The study done in old mice, if replicated in humans, could provide a strategy for helping elderly people clear the lungs more effectively and avoid infection. Previous studies […].
BioTech 365
AUGUST 16, 2020
EUR 159,90Scadenza: sabato ago-29-2020 22:54:12 CESTCompralo Subito per soli: EUR 159,90Compralo Subito | Aggiungi all’elenco degli oggetti che osservi Biotech365 : Eppendorf Research 8-Channels Micropipette 0.
The Pharma Data
AUGUST 16, 2020
Image copyright. PA Media. Public Health England is to be replaced by a new agency that will specifically deal with protecting the country from pandemics, according to a report. The Sunday Telegraph claims Health Secretary Matt Hancock will this week announce a new body modelled on Germany’s Robert Koch Institute. Ministers have reportedly been unhappy with the way PHE has responded to the coronavirus crisis.
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
BioTech 365
AUGUST 16, 2020
EUR 545,00Scadenza: lunedì ago-17-2020 23:27:40 CESTCompralo Subito per soli: EUR 545,00Compralo Subito | Aggiungi all’elenco degli oggetti che osservi Biotech365 : EPPENDORF 5415D Micro centrifuga FUNZIONA laboratorio Università BioMarketplace You want to propose your products or a Biotech Company, a … Continue reading →
The Pharma Data
AUGUST 16, 2020
Image copyright. Indoor Biotechnologies. Image caption. Dr James Hindley says T cells can create more antibodies if a person is exposed to the virus again. A company in Cardiff has developed a test for coronavirus T cells – which can potentially provide longer-term immunity to the virus than antibodies. The body develops T cells when fighting an infection and they can create more antibodies if a person is exposed again.
BioTech 365
AUGUST 16, 2020
Arvelle Announces Partnership with Durbin Across Europe Zug, Switzerland, 17 August 2020 – Arvelle Therapeutics, an emerging biopharmaceutical company focused on bringing innovative treatments to patients suffering from CNS disorders, is pleased to announce a collaboration with Durbin Group (Durbin), … Continue reading →
BioTech 365
AUGUST 16, 2020
Initiates new COVID-19 research and development program (K-NK-ID101) Expands the application of Kiadis’ K-NK technology into infectious diseases Announces collaboration with five premier Dutch institutions: Viroclinics-DDL; Harbour BioMed Netherlands; Sanquin Bloedvoorziening; Erasmus Medical Center; and the Utrecht University, each contributing … Continue reading →
Advertisement
The global landscape of clinical trials is rapidly changing as studies become more complex. An increasing number of sponsors are seeking enhanced flexibility in their supply chains to address a variety of clinical supply challenges, including patient demand and reducing delays. Demand-led supply and direct-to-patient distribution are next-generation solutions that are helping to meet these growing needs, allowing for more streamlined processes and patient-centric studies.
Expert insights. Personalized for you.
196 
Let's personalize your content